Add BrightSurf on Google Email

The future of independent primary care practices serving vulnerable populations depends on new policies that support health equity

A mixed-methods study examines the challenges faced by independent family physicians in urban communities, who serve socially vulnerable patients with limited support from healthcare entities. The researchers propose that health equity-focused policies and new payment models could help these practices stay afloat.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMar 25, 2024

Fathers’ perceptions of their teen sons’ readiness for sex linked to their likelihood to provide guidance on condom use

Researchers identified three key factors influencing fathers' assessments: completion of life milestones, cognitive-social emotional maturity, and preparedness to have sex safely. This study offers practical suggestions for engaging fathers in primary care to promote adolescent male correct and consistent condom use.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMar 25, 2024

The protein that protects insulin-producing cells

A study by Lund University researchers has identified the protein C3 as a protector of insulin-producing cells, providing hope for new treatments. The protein was found to shield cells from damage and death when present inside the cells, offering a potential target for therapies aimed at treating type 1 and type 2 diabetes.

SourceLund University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 21, 2024

Overeating and starving both damage the liver: Cavefish provide new insight into fatty liver disease

Researchers have identified a gene responsible for the development of starvation-induced fatty liver in cavefish, which are able to protect their liver due to reduced fat accumulation. This genetic basis has implications for understanding and addressing liver conditions in humans, including Type 2 diabetes and obesity.

SourceStowers Institute for Medical Research·JournalLife Science Alliance·TypeExperimental study·DateMar 18, 2024

The ACMG Foundation for Genetic and Genomic Medicine presents seven Next Generation fellowship awards at the 2024 ACMG Annual Clinical Genetics Meeting

The ACMG Foundation for Genetic and Genomic Medicine has presented seven Next Generation fellowship awards to promising early career professionals in medical genetics and genomics. The recipients include Xueyang Pan, Bianca Seminotti, and Adriel Yejin Kim, who will support their research projects with corporate donations from Pfizer, S...

‘Junk DNA’ no more: Johns Hopkins investigators develop method of identifying cancers from repeat elements of genetic code

Scientists at Johns Hopkins have developed a novel approach to identify cancer-causing repeats in DNA sequences, enabling non-invasive detection and monitoring of cancers. The ARTEMIS method uses machine learning to analyze cell-free DNA and distinguish between tumor and normal tissues with high accuracy.

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMar 13, 2024

Breakthrough in nanostructure technology for real-time color display

Researchers at UNIST have developed a groundbreaking technology that enables the real-time display of colors and shapes through changes in nanostructures. Utilizing block copolymers, they achieved the self-assembly of photonic crystal structures on a large scale, mimicking natural phenomena observed in butterfly wings and bird feathers.

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

Researchers at Weill Cornell Medicine found that patients with drug-resistant tuberculosis (TB) respond similarly to those with drug-sensitive TB when treated with bedaquiline-based second-line medications. The study suggests that treatment duration for drug-resistant TB may be shortened, potentially reducing mortality rates.

SourceWeill Cornell Medicine·JournalThe Journal of Infectious Diseases·DateFeb 27, 2024

Access to prescribed PCSK9 inhibitors remains a significant barrier leaving patients at risk for heart attacks and strokes

A new study reveals that utilization of PCSK9 inhibitors is low among high-risk patients, despite extensive evidence documenting their role in LDL-C reduction and the prevention of heart attacks. The study found that insurance coverage rejection or abandonment leads to significantly more cardiovascular events within 12 months.

SourceFamily Heart Foundation·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateFeb 20, 2024